D-66458-1 Class II Terminated

Recalled by Sandoz, Inc — Princeton, NJ

FDA drug recall D-66458-1 was initiated by Sandoz, Inc on Oct 9, 2013 and is designated Class II. Reason for recall: Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured… The recall status is terminated (terminated Jul 7, 2014). Affected quantity: 692 bottles (90 count).

Recall details

Product Type
Drugs
Report Date
Nov 13, 2013
Initiation Date
Oct 9, 2013
Termination Date
Jul 7, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
692 bottles (90 count)

Product description

Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92

Reason for recall

Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.

Distribution pattern

Nationwide

Code information

Lot DJ2744, Exp 12/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-66458-1
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-66458-1. Report a data issue: hello@regdatalab.com.